BIPROGY (8056) Q2 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2027 earnings summary
5 Nov, 2026Executive summary
H1 FY2027 revenue fell 2.0% YoY to ¥201.1bn and operating profit declined 20.0% to ¥17.1bn as hardware/software weakness and higher SG&A outweighed system-services growth; orders and backlogs rose strongly.
FY2027 guidance remained unchanged, supported by strong IT investment demand and revenue recognition expected to be weighted toward H2.
Financial highlights
H1 revenue was ¥201,130m vs ¥205,132m YoY; gross profit was ¥53,713m vs ¥53,736m.
Operating profit was ¥17,072m vs ¥21,350m; adjusted operating profit was ¥16,704m, down 19.1%, with adjusted operating margin of 8.3%, down 1.8pt.
Profit attributable to owners of parent was ¥11,150m vs ¥15,323m, down 27.2%; H1 basic EPS was ¥115.41 vs ¥156.60.
Q2 revenue rose 1.3% YoY to ¥109.7bn, while operating profit fell 15.0% to ¥10.9bn and parent-attributable profit fell 25.5% to ¥7.1bn.
SG&A rose 11.8% to ¥37.0bn on personnel, internal-system and AI-related costs; prior-year one-time equity-method affiliate income also weighed on the comparison.
Outlook and guidance
FY2027 forecast unchanged: revenue ¥470.0bn, gross profit ¥128.0bn, operating profit ¥48.4bn, profit before tax ¥48.0bn and parent-attributable profit ¥32.2bn.
Forecast operating margin is 10.3%; adjusted operating profit is ¥48.4bn with a 10.3% margin.
Revenue plus order backlog scheduled for FY2027 recognition reached ¥360.2bn at H1, 76.6% of forecast revenue, up 1.9pt YoY in progress rate.
Of ~¥6.0bn deferred from Q1 due to core-system renewal, ¥4.6bn was recognized in Q2 and ~¥1.4bn is scheduled for Q3; resolution within FY is expected with no forecast impact.
Latest events from BIPROGY
- Q1 operating profit rose 22% as revenue, orders, and backlog grew.8056
Q1 2024 - H1 revenue rose 11.8% and operating profit 21.9%; FY guidance stayed unchanged.8056
Q2 2024 - Strong DX demand lifted FYMar2024 results; growth investment supports FYMar2025 expansion.8056
Q4 2024 - 9M revenue and operating profit grew; full-year forecasts and dividends rose.8056
Q3 2024 - Deferred product sales cut Q1 profit, while orders surged and FY2027 guidance stayed unchanged.8056
Q1 2027 - Q1 revenue and operating profit grew, with full-year guidance unchanged.8056
Q1 2025 - Revenue and operating profit rose, but net profit declined; full-year guidance was unchanged.8056
Q2 2025 - Revenue and orders grew, lifting the FY revenue forecast despite lower net profit.8056
Q3 2025 - Revenue and operating profit grew; FY2027 revenue target rose to ¥440bn.8056
Q4 2025